XML 78 R24.htm IDEA: XBRL DOCUMENT v2.4.0.8
Employee Compensation Plans
12 Months Ended
Dec. 31, 2013
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Employee Compensation Plans
16. Employee compensation plans

Share-based Compensation

The Company has share-based compensation plans which are accounted for at fair value in accordance with the applicable accounting guidance. The Company estimates the fair value of share-based awards using the Black-Scholes model and applies to it a forfeiture rate based on historical experience. The accuracy of this forfeiture rate is reviewed at least annually for reasonableness. Key assumptions used to estimate the fair value of share-based awards include the expected term and the expected volatility of the Company’s Class A Stock over the term of the award, the risk-free interest rate over the expected term, and the Company’s expected annual dividend yield. The Company believes that the valuation technique and the approach utilized to develop the underlying assumptions are appropriate in calculating fair values of the Company’s outstanding unvested share-based awards.

The fair value of each award of stock options was estimated on the grant date using the Black-Scholes model with the following assumptions:

 

     Grant Date Assumptions  
     2013     2012     2011     2010     2009     2008  

Expected term (1)

     5 years        5 years        5 years        4.5 years        5 years        2.4 years   

Expected volatility factor (2)

     53.82     54.95     52.52     48.58     39.17     36.41

Risk-free interest rate (3)

     0.84     0.70     2.00     2.62     3.32     2.13

Actual dividends (4)

   $ 0.44      $ 0.44      $ 0.44      $ 0.44      $ 0.44      $ 0.44   

 

(1) The expected term was determined based on actual awards.
(2) The volatility factor was measured using the weighted average of historical daily price changes of the Company’s Class A Stock over a historical period commensurate to the expected term of the awards.
(3) The risk-free interest rate was based on periods equal to the expected term of the awards based on the U.S. Treasury yield curve in effect at the time of grant.
(4) Actual dividends were used to compute the expected annual dividend yield.

Equity Incentive Plan

Under the Company’s 2006 Equity Incentive Plan, adopted December 11, 2006 and amended December 2011, and its 1996 Equity Incentive Plan, as amended March 10, 2005 (together “EIP”), the Compensation Committee of the Board of Directors of the Company may grant options to purchase Class A Stock, Class A Stock awards and restricted Class A Stock awards to officers and key employees of the Company and its subsidiaries. Options are generally granted for a five-year term and generally vest at the rate of 25% of the amount granted on the second anniversary of the grant, 25% on the third anniversary of the grant, 25% on the fourth anniversary of the grant and 25% six months before expiration.

Stock option activity under the EIP since January 1, 2012 is summarized as follows:

 

     Year Ended December 31,  
     2013      2012  
     Number of
Options
    Weighted Average
Exercise Price
     Number of
Options
    Weighted Average
Exercise Price
 

Options outstanding at beginning of year

     86,803      $ 23.35         164,193      $ 29.04   

Options granted

     951        17.20         1,590        19.31   

Options exercised

     (12,165     12.30         —          —     

Options forfeited or expired

     (3,016     39.45         (78,980     35.09   
  

 

 

   

 

 

    

 

 

   

 

 

 

Options outstanding at end of year

     72,573      $ 24.46         86,803      $ 23.35   
  

 

 

   

 

 

    

 

 

   

 

 

 

Options vested at end of year

     45,683      $ 23.34         36,023      $ 22.59   
  

 

 

   

 

 

    

 

 

   

 

 

 

Weighted average fair value of options granted during the year

   $ 6.60         $ 7.67     
  

 

 

      

 

 

   

The aggregate intrinsic value of options outstanding as of December 31, 2013 was $202,700. The aggregate intrinsic value of vested options as of December 31, 2013 was $186,800. The aggregate intrinsic value of options that are expected to vest is $198,100 as of December 31, 2013.

The following table summarizes stock options outstanding and exercisable as of December 31, 2013:

 

Range of Exercise Prices

   Number of
Options
Outstanding
     Weighted
Average
Remaining
Contractual Life
     Weighted
Average
Exercise Price of
Outstanding
Options
     Number of
Options
Exercisable
(Vested)
     Weighted
Average
Exercise Price of
Vested Options
 

$9.60 - $25.00

     20,240         0.86 Years       $ 14.80         16,350       $ 13.38   

$25.01.00 - $39.45

     52,333         1.72 Years         28.19         29,333         28.89   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

$9.60 - $39.45

     72,573         1.48 Years       $ 24.46         45,683       $ 23.34   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

The following table summarizes the status of the Company’s non-vested options for the year ended December 31, 2013:

 

     Number of
Options
    Weighted
Average Fair
Value
 

Nonvested at beginning of year

     50,780      $ 9.49   

Granted

     951        6.60   

Vested

     (24,841     7.90   
  

 

 

   

 

 

 

Nonvested at end of year

     26,890      $ 10.86   
  

 

 

   

 

 

 

In the year ended December 31, 2013, the Company has included approximately $158,200 ($164,200 in 2012 and $322,500 in 2011) of compensation expense in its consolidated statement of operations relating to the expensing of stock options.

As of December 31, 2013, there was approximately $169,600 of total unrecognized compensation cost related to unvested share-based compensation arrangements granted under the EIP. The cost is expected to be recognized over a weighted average period of 1.48 years.

Employee Share Plan

On March 10, 2005, the Company approved the Oppenheimer & Co. Inc. Employee Share Plan (“ESP”) for employees of the Company and its subsidiaries to attract, retain and provide incentives to key management employees. The Compensation Committee of the Board of Directors of the Company may grant stock awards and restricted stock awards pursuant to the ESP. ESP awards are being accounted for as equity awards and valued at grant date fair value. ESP awards are generally awarded for a three or five year term and 100% vest at the end of the term.

The Company has awarded restricted Class A Stock to certain employees as part of their compensation package pursuant to the ESP. These awards are granted from time to time throughout the year based upon the recommendation of the Compensation Committee of the Board of Directors of the Company. These ESP awards are priced at fair value on the date of grant and typically require the completion of a service period (determined by the Compensation Committee). Dividends may or may not accrue during the service period, depending on the terms of individual ESP awards.

The following table summarizes the status of the Company’s non-vested restricted Class A Stock awards for the year ended December 31, 2013:

 

     Number of Class
A Shares

Subject to
ESP/EIP Awards
    Weighted
Average Fair
Value
     Remaining
Contractual
Life
 

Nonvested at beginning of year

     848,068      $ 19.39         2.3 Years   

Granted

     506,470        16.14         2.8 Years   

Vested

     (58,062     23.53         —     

Forfeited or expired

     (49,000     20.39         —     
  

 

 

   

 

 

    

 

 

 

Nonvested at end of year

     1,247,476      $ 17.87         2.0 Years   
  

 

 

   

 

 

    

 

 

 

At December 31, 2013, all outstanding restricted Class A Stock awards were non-vested. The aggregate intrinsic value of restricted Class A Stock awards outstanding as of December 31, 2013 was approximately $30.9 million. The aggregate intrinsic value of restricted Class A Stock awards that are expected to vest is $30.0 million as of December 31, 2013. In the year ended December 31, 2013, the Company included approximately $5.0 million ($3.4 million in 2012 and $3.7 million in 2011) of compensation expense in its consolidated statements of operations relating to restricted Class A Stock awards.

As of December 31, 2013, there was approximately $10.1 million of total unrecognized compensation cost related to unvested restricted Class A Stock awards. The cost is expected to be recognized over a weighted average period of 2.0 years.

At December 31, 2013, the number of shares of Class A Stock available under the EIP and the ESP, but not yet awarded, was 1,116,182.

On January 2, 2014, the Company awarded 14,000 restricted shares of Class A Stock to its non-employee directors under the EIP. These shares of Class A Stock will vest as follows: 25% on July 1, 2014, 2015, 2016 and 2017.

On January 29, 2014, the Company awarded 124,000 restricted shares of Class A Stock to an executive officer of the Company pursuant to the EIP. This award cliff vests on January 28, 2019 and will be expensed over 5 years.

On January 29, 2014, the Company awarded a total of 179,375 restricted shares of Class A Stock to current employees pursuant to the ESP. Of these restricted shares, 136,250 shares will cliff vest in three years and 43,125 shares will cliff vest in five years. These awards will be expensed over the applicable three or five year vesting period.

On January 29, 2014, the Company awarded a total of 2,976 options to purchase Class A Stock to current employees pursuant to the EIP. These options will be expensed over 4.5 years (the vesting period).

On February 26, 2014, the Company adopted the Oppenheimer Holdings Inc. 2014 Incentive Plan (the “OIP”) which pursuant to its terms amends and restates each of the EIP and ESP and incorporates each of the EIP and ESP into the OIP. A total of 27,500 restricted shares of Class A Stock were awarded to employees of the Company pursuant to the OIP on February 26, 2014 subject to stockholder approval of the OIP at the 2014 annual meeting of stockholders.

Stock Appreciation Rights

The Company has awarded Oppenheimer stock appreciation rights (“OARs”) to certain employees as part of their compensation package based on a formula reflecting gross production and length of service. These awards are granted once per year in January with respect to the prior year’s production. The OARs vest five years from grant date and will be settled in cash at vesting. The OARs are being accounted for as liability awards and are revalued on a monthly basis. The adjusted liability is being amortized on a straight-line basis over the vesting period.

The fair value of each OARs award was estimated as at December 31, 2013 using the Black-Scholes model.

 

Grant Date

   Number of
OARs
Outstanding
     Strike Price      Remaining
Contractual
Life
     Fair Value at
December 31, 2013
 

January 12, 2009

     324,200       $ 12.74         11 Days       $ 12.04   

January 19, 2010

     267,680         30.68         1 Year         1.46   

January 13, 2011

     366,050         26.35         2 Years         3.02   

January 19, 2012

     406,040         18.94         3 Years         8.09   

January 14, 2013

     454,570         15.94         4 Years         10.45   
  

 

 

          
     1,818,540            
  

 

 

          

Total weighted average values

      $ 20.30         2.3 Years       $ 7.39   

At December 31, 2013, all outstanding OARs were unvested. At December 31, 2013, the aggregate intrinsic value of OARs outstanding and expected to vest was $10.3 million. In the year ended December 31, 2013, the Company included approximately $4.1 million ($590,000 in 2012 and net credit of $2.9 million in 2011) in compensation expense in its consolidated statement of operations relating to OARs awards. The liability related to the OARs was approximately $6.7 million as of December 31, 2013.

As of December 31, 2013, there was approximately $5.5 million of total unrecognized compensation cost related to unvested OARs. The cost is expected to be recognized over a weighted average period of 2.3 years.

On January 14, 2014, 543,370 OARs were awarded to Oppenheimer employees related to fiscal 2013 performance. These OARs will be expensed over 5 years (the vesting period).

Defined Contribution Plan

The Company, through its subsidiaries, maintains a defined contribution plan covering substantially all full-time U.S. employees. The Oppenheimer & Co. Inc. 401(k) Plan provides that Oppenheimer may make discretionary contributions. Eligible Oppenheimer employees could make voluntary contributions which could not exceed $17,500, $17,000 and $16,500 per annum in 2013, 2012 and 2011, respectively. The Company made contributions to the 401(k) Plan of $1.3 million, $1.1 million and $1.9 million in 2013, 2012 and 2011, respectively.

Deferred Compensation Plans

The Company maintains an Executive Deferred Compensation Plan (“EDCP”) and a Deferred Incentive Plan (“DIP”) in order to offer certain qualified high-performing financial advisers a bonus based upon a formula reflecting years of service, production, net commissions and a valuation of their clients’ assets. The bonus amounts resulted in deferrals in fiscal 2013 of approximately $8.5 million ($8.1 million in 2012 and $6.8 million in 2011). These deferrals normally vest after five years. The liability is being recognized on a straight-line basis over the vesting period. The EDCP also includes voluntary deferrals by senior executives that are not subject to vesting. The Company maintains a Company-owned life insurance policy, which is designed to offset approximately 60% of the EDCP liability. The EDCP liability is being tracked against the value of a benchmark investment portfolio held for this purpose. At December 31, 2013, the Company’s liability with respect to the EDCP and DIP totaled $50.1 million and is included in accrued compensation on the consolidated balance sheet at December 31, 2013.

In addition, the Company is maintaining a deferred compensation plan on behalf of certain employees who were formerly employed by CIBC World Markets. The liability is being tracked against the value of an investment portfolio held by the Company for this purpose and, therefore, the liability fluctuates with the fair value of the underlying portfolio. At December 31, 2013, the Company’s liability with respect to this plan totaled $15.5 million.

The total amount expensed in 2013 for the Company’s deferred compensation plans was $17.8 million ($12.1 million in 2012 and $5.5 million in 2011).